Skip to main content

Peer Review reports

From: Efficacy and safety of blonanserin versus risperidone in the treatment of schizophrenia: a systematic review and meta-analysis of randomized controlled trials

Original Submission
1 Jun 2023 Submitted Original manuscript
1 Jul 2023 Reviewed Reviewer Report
31 Jul 2023 Reviewed Reviewer Report
5 Aug 2023 Reviewed Reviewer Report
23 Aug 2023 Author responded Author comments - Qian Xu
Resubmission - Version 2
23 Aug 2023 Submitted Manuscript version 2
25 Aug 2023 Author responded Author comments - Qian Xu
Resubmission - Version 3
25 Aug 2023 Submitted Manuscript version 3
3 Sep 2023 Reviewed Reviewer Report
4 Sep 2023 Reviewed Reviewer Report
22 Sep 2023 Author responded Author comments - Qian Xu
Resubmission - Version 4
22 Sep 2023 Submitted Manuscript version 4
27 Sep 2023 Reviewed Reviewer Report
Resubmission - Version 5
Submitted Manuscript version 5
Publishing
30 Sep 2023 Editorially accepted
11 Oct 2023 Article published 10.1186/s12888-023-05240-7

You can find further information about peer review here.

Back to article page